|4Jul 6, 4:56 PM ET

Decker Patrick 4

4 · Xylem Inc. · Filed Jul 6, 2023

Insider Transaction Report

Form 4
Period: 2023-07-03
Decker Patrick
DirectorPresident & CEO
Transactions
  • Sale

    Common Stock

    2023-07-03$111.53/sh68,126$7,597,834319,087 total
  • Sale

    Common Stock

    2023-07-03$111.82/sh31,523$3,525,053287,564 total
  • Exercise/Conversion

    Common Stock

    2023-07-03$35.96/sh+99,649$3,583,378387,213 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2023-07-03$35.96/sh99,649$3,583,37899,648 total
    Exercise: $35.96Exp: 2025-02-24Common Stock (99,649 underlying)
Footnotes (4)
  • [F1]The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on February 10, 2023.
  • [F2]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $110.77 to $111.7699. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F3]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $111.77 to $112.7699. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F4]The February 24, 2015 option grant vested one-third on February 24, 2016, February 24, 2017 and February 24, 2018.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT